Search for: "Merck, Sharpe "
Results 21 - 40
of 266
Sort by Relevance
|
Sort by Date
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
23 Sep 2022, 9:39 am
selected address issues such as SPC protection for combination products, double patenting, prosecution history estoppel and the influence of declarations made by the patentee in parallel proceedings, the possibility for national courts to request technical opinions from the EPO under Art. 25 EPC, and the disappearance of the cautio iudicatum solvi that was sometimes required from foreign plaintiffs launching (patent) proceedings in Belgium.SPC’s for combination products: still more questions… [read post]
18 Jul 2022, 12:53 am
The assembly includes a housing, a removable distal cap fabricated from a polymer to maintain a sterile environment for the device, and a sharp housed within. [read post]
11 Jul 2022, 9:15 am
In In re Rotavirus Vaccines Antitrust Litigation, Merck Sharp & Dohme Corp. secured a victory in the Third Circuit, which held in a precedential decision that the plaintiffs’ antitrust bundling claims must be arbitrated. [read post]
11 Jul 2022, 9:15 am
In In re Rotavirus Vaccines Antitrust Litigation, Merck Sharp & Dohme Corp. secured a victory in the Third Circuit, which held in a precedential decision that the plaintiffs’ antitrust bundling claims must be arbitrated. [read post]
11 Jul 2022, 9:15 am
In In re Rotavirus Vaccines Antitrust Litigation, Merck Sharp & Dohme Corp. secured a victory in the Third Circuit, which held in a precedential decision that the plaintiffs’ antitrust bundling claims must be arbitrated. [read post]
30 Mar 2022, 7:01 pm
The case is noteworthy because it contains a cogent and well-reasoned exploration of many of the issues flowing from the Supreme Court’s decision in Merck Sharp & Dohme Corp. v. [read post]
30 Mar 2022, 4:31 am
Ltd [2022] FCAFC 39 (Ono) and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (MSD). [read post]
24 Mar 2022, 11:25 am
Supreme Court made a ruling on the federal preemption legal issue in these Fosamax cases in May 2019 (see Merck Sharp & Dohme Corp. v. [read post]
23 Mar 2022, 11:17 pm
Ltd [2022] FCAFC 39 (‘Ono’); and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (‘MSD’). [read post]
28 Oct 2021, 6:06 am
The importance of proving CGK was highlighted in a recent IP High Court case (Merck Sharp & Dohme Corp. v. [read post]
28 Oct 2021, 6:06 am
The importance of proving CGK was highlighted in a recent IP High Court case (Merck Sharp & Dohme Corp. v. [read post]
17 Oct 2021, 9:24 pm
Ltd v Commissioner of Patents [2021] FCA 643, and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947. [read post]
7 Jul 2021, 11:44 pm
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January 2016 16 April 2015 Duration… [read post]
25 Jun 2021, 4:15 am
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
21 Jun 2021, 1:18 pm
The Supreme Court discussed in Wyeth and later clarified in Merck Sharp & Dohme Corp. v. [read post]
Foreign Judgments: The Limits of Transnational Issue Estoppel, Reciprocity, and Transnational Comity
26 May 2021, 8:40 pm
Written by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University In Merck Sharp & Dohme Corp v Merck KGaA [2021] SGCA 14, a full bench of the Singapore Court of Appeal addressed the limits of transnational issue estoppel in Singapore law, and flagged possible fundamental changes to the common law on the recognition and enforcement of foreign judgments in Singapore. [read post]
5 Apr 2021, 6:49 am
” Kerner further writes that he is “most concerned by the agency’s conduct involving the 2018 Merck Sharp and Dohme inspection. [read post]
5 Apr 2021, 6:49 am
” Kerner further writes that he is “most concerned by the agency’s conduct involving the 2018 Merck Sharp and Dohme inspection. [read post]
12 Mar 2021, 6:33 am
In this week’s featured patent applications, we cover the latest from ExxonMobil, Roche, Boston Scientific, Abbott, Medtronic, Merck, Paypal, Intel, Apple, IBM, and Microsoft. [read post]